Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Orthocell Ltd ( (AU:OCC) ) has issued an update.
Orthocell Ltd announced the issuance of 2,000,000 unquoted options, set to expire on August 31, 2028, with an exercise price of $1.53. This issuance is part of a previously announced transaction and is not intended to be quoted on the ASX, potentially impacting the company’s capital structure and offering strategic flexibility in its financial operations.
The most recent analyst rating on (AU:OCC) stock is a Hold with a A$1.50 price target. To see the full list of analyst forecasts on Orthocell Ltd stock, see the AU:OCC Stock Forecast page.
More about Orthocell Ltd
Orthocell Ltd is a company operating in the biotechnology industry, focusing on the development and commercialization of regenerative medicine products. The company primarily targets the treatment of soft tissue injuries and musculoskeletal conditions, aiming to improve patient outcomes through innovative therapies.
Average Trading Volume: 619,748
Technical Sentiment Signal: Buy
Current Market Cap: A$292.5M
For an in-depth examination of OCC stock, go to TipRanks’ Overview page.